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Abstract
VacA, the vacuolating cytotoxin A of Helicobacter pylori, induces apoptosis in epithelial cells of the gastic mucosa
and in leukocytes. VacA is released by the bacteria as a protein of 88 kDa. At the outer surface of host cells, it
binds to the sphingomyelin of lipid rafts. At least partially, binding to the cells is facilitated by different receptor
proteins. VacA is internalized by a clathrin-independent mechanism and initially accumulates in GPI-anchored
proteins-enriched early endosomal compartments. Together with early endosomes, VacA is distributed inside the
cells. Most of the VacA is eventually contained in the membranes of vacuoles. VacA assembles in hexameric
oligomers forming an anion channel of low conductivity with a preference for chloride ions. In parallel, a
significant fraction of VacA can be transferred from endosomes to mitochondria in a process involving direct
endosome-mitochondria juxtaposition. Inside the mitochondria, VacA accumulates in the mitochondrial inner
membrane, probably forming similar chloride channels as observed in the vacuoles. Import into mitochondria is
mediated by the hydrophobic N-terminus of VacA. Apoptosis is triggered by loss of the mitochondrial membrane
potential, recruitment of Bax and Bak, and release of cytochrome c.
Keywords: Helicobacter pylori, vacuolating cytotoxin A, apoptosis, lipid rafts, endosomes, vacuoles, mitochondrial
targeting, mitochondrial inner membrane, ion channel, cytochrome c
Review
VacA, the vacuolating cytotoxin A, is one of the major
virulence factors released by Helicobacter pylori. VacA is
a protein of about 88 kDa that easily assembles in
defined oligomeric complexes, forming anion channels
in target membranes. The name refers to the capability
of the toxin to cause a formation of large vacuoles in
cultured cells [1,2]. However, VacA is also implicated in
other activities, including interactions with the immune
system, modifications of the permeability of polarized
epithelial cell monolayers, and induction of apoptosis
[3,4]. The first observations of VacA-dependent apopto-
sis were published more than 10 years ago [5,6]. Since
then, numerous projects on VacA were carried out, but
it was difficult to reconcile the divergent results. Only
recently, a unifying model is emerging [7,8], suggesting
that VacA-induced cell death is essentially dependent on
a peculiar traffic route of VacA inside the host cells.
In this review, we will first ask for the evidence that
VacA is of any relevance for the induction of cell death
in the infected tissues. The next section gives a short
summary on the structure and the molecular properties
of the toxin. The following sections give a detailed
description of the traffic route of VacA: I, binding to
target cells, II, lipid rafts and endocytosis, III, vacuola-
tion, IV, mitochondria. In the final section, we will dis-
cuss the possible relation between mitochondrial
targeting and VacA acting as a trigger of apoptosis.
The cellular effect: VacA triggers apoptosis
H. pylori has a unique capability to survive in the mucus
layer of the stomach. In many cases, the infection is
acquired early in childhood and persists throughout the
entire life of the host [3,8]. About 80-90% of the bacteria
are mobile within the mucus, a fraction of 10-20% is
found in direct contact with the surface of the epithelial
cells [9]. Some bacteria may even enter host cells and
survive for some time in an intracellular compartment
[8,10]. Under normal physiological conditions, the
epithelial cells of the gastric mucosa are constantly
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cells undergo apoptosis, the remnants are exfoliating
into the gastric lumen [11,12]. The rate of this process
is significantly increased upon infection by H. pylori
[13-15]. Remarkably, even excessive apoptosis of the
epithelial cells is not necessarily a reason for ulcer for-
mation. In most cases, the integrity of the epithelium is
maintained by the induction of a secondary hyperproli-
ferative response. The mucosal cells are replaced by
cells migrating from the neck segments of the gastric
glands [16]. In fact, about ha l fo ft h ew o r l dp o p u l a t i o n
is infected by H. pylori, but only in about 15% of the
cases the infection causes peptic ulceration [17-19].
What is the reason for the increased rate of cell death
in the presence of H. pylori? Initial studies concentrated
on a possible involvement of the CD95 (APO-1/FAS)
system [20-22]. It was observed that infection with H.
pylori entailed an enhanced Fas receptor expression.
However, the reason of this effect was not clear. More-
over, data on other pathogens demonstrated that bac-
teria are able to trigger apoptosis by many different
means, including specific effector proteins that act inside
the host cells [23]. VacA was already known to be one
o ft h em a j o rv i r u l e n c ef a c t o r so fH. pylori,a n di th a d
been observed that VacA is able to enter different target
cells. It was therefore tested if this protein may be suffi-
cient to trigger apoptosis. In fact, several independent
studies confirmed that cells incubated with purified
VacA showed all signs of apoptosis [5,6,24-26]. It is now
generally assumed that several effects contribute to
apoptosis in H. pylori-infected tissues, including a con-
tribution of the extrinsic, receptor-mediated pathway
[27-29]. However, it is clear that H. pylori-induced
apoptosis is also possible independently of death recep-
tors [5,6,24-26,30], and the VacA toxin appears to be
the most prominent mediator [4,31].
VacA-dependent effects are also observed with leuko-
cytes and it is well possible that this activity is of much
higher pathological significance as compared to the
enhanced turnover of the epithelial cells.
Infection of the mucosa by H. pylori is accompanied
with a significant disruption of the epithelial barrier
function, permitting access of VacA to the gastric sub-
mucosa [3,32,33]. Already very low concentrations of
VacA are sufficient to causes an efficient inhibition of
the proliferation of the T cells due to down-regulation
of Interleukin-2 (IL-2) transcription [34-37]. Moreover,
the number of T cells can also be reduced indepen-
dently of IL-2, possibly by apoptotic depletion [38-40].
Similar as with epithelial cells, apoptosis of T cells was
originally thought to be due to death receptor signalling
but later shown to be mediated by the mitochondrial
pathway [30]. Apoptosis was reported both for T- and
B-cell lines [41]. Moreover, H. pylori is also able to
cause apoptosis of human monocytes and macrophages.
Again, cell death appears to depend on a participation
of mitochondrial factors [42,43]. There is some indica-
tion that all subsets of leukocytes, including granulo-
cytes and dendritic cells, may be susceptible to VacA
[36]. However, there are also some data suggesting that
in particular granulocytes and dendritic cells may be
resistant against VacA-dependent apoptosis [42,44].
Although there is compelling evidence that H. pylori
virulence factors are able to trigger apoptosis of different
leukocytes if applied in vitro, data are lacking to esti-
mate the relevance of leukocyte apoptosis and the role
of VacA in the infected tissues. It was questioned if the
density of H. pylori in the mucus layer is sufficient to
achieve a sufficient concentration of VacA to trigger
apoptosis of leukocytes in the submucosa [33]. However,
the bacteria are obviously successful in establishing a
state of drastic immune suppression in their immediate
vicinity. It may be speculated that inhibition of IL-2
activities and induction of apoptosis correspond to two
different lines of defence which allow the bacteria to
survive in the immediate neighbourhood of a chronic
inflammation.
The structure: VacA forms hexameric anion
channels
What are the features that enable VacA to trigger cell
death? VacA is initially synthesized in the bacteria as a
single polypeptide of about 140 kDa, in most cases com-
prising 1.287 residues [45-48]. The protein is subse-
quently released by type V-secretion. In this context, the
N-terminal leader sequence of 33 residues and the C-
terminal autotransporter domain of about 33 kDa are
cleaved, yielding a mature toxin of 88.2 kDa [49]. The
polypeptide can be further processed into an N-terminal
fragment of 33.4 kDa (named p34 or p37, residues 1-
311) and a C-terminal fragment of 54.8 kDa (named
p55 or p58, comprising residues 320-821), both parts
stay associated by non-covalent interactions. The rele-
vance of the cleavage is not clear, it is not required for
VacA activity. However, many data have shown that the
N-terminal domain is essential in the toxic activity of
VacA while the C-terminal domain is essential in bind-
ing to target membranes [3,4].
VacA is able to assemble in flower-shaped hexameric
structures. These can form both free in solution and
after insertion in membranes. The complexes can have a
mass of nearly 1000 kDa, indicating that they may con-
tain 12 VacA polypeptides [50-52]. The complexes prob-
ably form by association of two donut-like hexamers.
They dissociate into monomers at pH < 4.5 [51]. At
least under some conditions, VacA also forms stable
heptameric complexes, however, hexamers represent the
dominant form of the toxin [52].
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toxin is its capability to form anion channels of low con-
ductivity [53-55]. Oligomeric VacA can act as a chloride
channel of about 10 pS. The conductivity is completely
i n h i b i t e db yt h en o n s p e c i f i cc h l o r i d ec h a n n e lb l o c k e r
NPPB (5-nitro-2-(3-phenylpropylamino)benzoic acid
[55,56]. N-terminal segments of p58 may be involved in
pore formation [57], however, we recently found that
isolated p34 alone is sufficient to form the ion channel
[58]. Unfortunately, so far no crystal structure of the
holo-toxin was resolved. The N-terminal part of VacA is
prone to aggregation, making it difficult to obtain crys-
tals. The structure of the ion-conducting channel is
therefore unknown. The C-terminal parts of VacA were
crystallized separately some years ago, the structure
revealed an impressive array of b-sheets [59]. Eventually,
it should be noted that not only the precise structure of
VacA is unknown, but also the topology of the VacA
complexes in membranes. The determination of the
VacA structure and membrane topology is still one of
the big challenges in the field of VacA research.
The traffic route: (I) Binding of VacA to target
cells
Electrophysiological studies showed a successful integra-
tion of functional VacA into artificial membranes in the
absence of any accessory proteins. However, targeting to
host cells is obviously facilitated by distinct receptor
structures [60]:
Epithelial cells
Association of VacA with epithelial cells was found to
involve interactions with RPTPa and RPTPb, two struc-
turally unrelated receptor-like protein tyrosine phospha-
tases [61-65]. The relevance of VacA binding to these
phosphatases was questioned because it is unclear if
binding of VacA to RPTPa or RPTPb has a significant
impact on subsequent signalling or protein traffic [66].
However, it was reported that mice deficient in RPTPb
show a remarkable resistance to gastric ulcer induction
by VacA [67], suggesting that at least RPTPb may play a
substantial role in VacA toxicity.
Leukocytes
Binding of VacA to T-cells and subsequent endocytosis
were reported to be mediated by the integrin b2 subunit
CD18 [36]. Together with the integrin a subunit CD11a,
CD18 forms a heterodimeric transmembrane receptor
on T cells named LFA-1 (lymphocyte function-asso-
ciated antigen-1). Interestingly, the same protein was
also reported to bind the leukotoxin of the dental patho-
gen Actinobacillus actinomycetemcomitans [68] and the
Bordetella pertussis adenylate cyclase toxin (CyaA) [69].
LFA-1 is also exposed on the surface of other
leukocytes, including granulocytes, macrophages, dendri-
tic cells, B cells and NK cells, suggesting that the affinity
for LFA-1 may be of general importance in the immun-
suppressive effects of VacA [36]. However, also the
functional consequences of VacA binding to LFA-1 are
a matter of debate. It was argued that it is not suffi-
ciently clear if LFA-1 primarily acts as a mediator of
VacA endocytosis, or if LFA-1 is merely a mediator of
intracellular signalling pathways [8]. Interestingly, new
data have recently shown that uptake of VacA by T cells
requires phosphorylation of the cytoplasmic tail of
CD18, catalyzed by members of the protein kinase C
(PKC) family [37]. There is evidence that also RPTPa
may be phosphorylated by PKCs, indicating the possibi-
lity of a common mechanism of VacA internalization
both in leukocytes and in epithelial cells [37].
Although both LFA-1 and the phosphatases RPTPa
and RPTPb are components of signal transduction sys-
tems, there seems to be no direct participation in a sig-
nalling pathway leading to VacA-dependent apoptosis.
However, binding to receptor proteins may strongly
facilitate the endocytosis of VacA (Figure 1).
The traffic route: (II) Lipid rafts and endocytosis
It has been known for a long time that after binding to
a cell surface, VacA can efficiently be internalized [70].
The toxin is subsequently found in endosomes, the pro-
cess is clathrin-independent [71]. In spite of uncertain-
ties regarding the precise role of cellular receptor
proteins, there is a general consensus with respect to
lipid rafts as major site for uptake of VacA
[8,60,65,72,73]. Sphingomyelin, a key component of the
lipid rafts, was demonstrated to bind VacA directly and
to facilitate its internalization [66]. VacA also binds to
several glycosphingolipids, at least in vitro [74], but the
relevance of this affinity for VacA toxicity has not been
clarified.
A l r e a d yi n2 0 0 0i tw a sf o u n dt h a tu p t a k eo fV a c A
depends on the presence of GPI-anchored proteins (gly-
cosylphosphatidylinositol-anchored proteins) in the
membrane [71]. GPI-anchored proteins can be delivered
to a special subset of endosomes via a distinct Cdc42-
dependent, clathrin-independent pinocytic pathway [75].
VacA was shown to follow this pathway and to accumu-
late in the corresponding GPI-anchored proteins-
enriched early endosomal compartments (GEECs)
[76-78]. Most GPI-anchored are subsequently recycled
back to the plasma membrane. VacA avoids this step
and accumulates in early endosomes that are character-
ized by their coating with the small GTPase Rab5.
Surprisingly, the VacA-containing early endosomes
attract actin, and are subsequently moved inside the
cytosol by F-actin comet tails [78]. The actin assembles
preferentially at one side of an endosome, and the
Rassow Cell Communication and Signaling 2011, 9:26
http://www.biosignaling.com/content/9/1/26
Page 3 of 9endosome is then propelled forward by the growth of
the actin fibers. The principle of motility is similar to
the mechanism of F-actin-dependent movements of Lis-
teria monocytogenes inside the cytosol of host cells [79].
If the formation of F-actin is blocked, the mobility and
all subsequent steps of toxicity are inhibited [78]. If
actin-mediated mobility is permitted, VacA takes at least
two different pathways: (1.) Most of VacA is subse-
quently found in vesicles that are labelled by the small
G T P a s eR a b 7a n dt h u sd e f i n e da sl a t ee n d o s o m e s .
Accumulation in late endosomes initiates the formation
of the vacuoles that were the reason to name the toxin
the “vacuolating cytotoxin”. (2.) In parallel, a smaller
fraction of VacA can be transferred from the early endo-
somes to mitochondria. By interactions with mitochon-
dria, VacA eventually has the opportunity to trigger
apoptosis.
The traffic route: (III) Vacuolation
If purified VacA is added to cells in culture medium, a
high number of vacuoles emerge inside the cells [3,4]. It
is conceivable that this drastic effect may significantly
contribute to the toxicity of VacA in the infected
mucosa, but surprisingly little is known about the
impact of the vacuolation in vivo. The vacuoles resemble
late endosomes, in particular they are covered with the
small GTP-binding protein Rab7 and they contain V-
type ATPases [80-83]. VacA was shown to primarily
mediate an influx of chloride ions into the endosomes.
The accumulation of negatively charged chloride ions
inside the endosomes strongly facilitates the activity of
the V-type ATPases. VacA thereby indirectly increases
the ATP-dependent acidification of the endosomes. Due
to the strong acidification, weak bases are easily trapped
inside the endosomes, eventually causing an osmotic
swelling of the organelles [83].
There are some data indicating that VacA may also
act as a mediator of pyruvate transport [83]. However,
the conductivity of the VacA ion channel is extremely
low, suggesting that the inner diameter of the channel
should be too small to accommodate complex molecules
such as pyruvate or other organic acids [58]. Perhaps
the discrepancies will be resolved once the precise struc-
ture of the VacA complexes has been elucidated. The
possible permeability of VacA for pyruvate is also of
relevance with respect to the question if VacA in the
plasma membrane is able to mediating a release of
monomeric VacA
binding to sphingomyelin of
lipid rafts
receptor protein
Clí
Cdc42-dependent
endocytosis
GPI-anchored proteins-enriched
compartment (GEEC)
early endosome binding Rab5,
binding of actin
         motility in the cytosol
 
formation of Rab7-positive
late endosomes
containing V-type ATPases
          formation of vacuoles
endosome-mitochondria juxtaposition
formation of
chloride channels
in mitochondrial
inner membrane
loss of membrane potential, recruitment of Bax and Bak
TOM
Pathway to apoptosis Pathway to formation of vacuoles
apoptosis
Figure 1 Traffic of VacA. Uptake of VacA into host cells is initiated
by binding to lipid rafts. This step can be facilitated by receptor
proteins (such as the receptor-like protein tyrosine phosphatases
RPTPa and RPTPb, or - on the surface of leukocytes - by the
integrin b2 subunit CD18). Inside the lipid rafts, VacA binds to
sphingomyelin. Subsequent endocytosis is dependent on Cdc42, a
small GTPase of the Rho subfamily. The endocytosis is independent
of clathrin. VacA accumulates in an early endosomal compartment
enriched in GPI-anchored proteins (GEEC). The endosomes recruit
cytosolic actin which forms comet-like structures. Growth of the
actin fibers causes a significant motility of the endosomes in the
cell. Fractions of the endosomes bind the small GTPase Rab5 and
are therefore classified as early endosomes. The early endosomes
undergo maturation to late endosomes, releasing Rab5 and binding
Rab7. VacA in cooperation with V-type ATPases causes swelling of
the endosomes and thereby a formation of vacuoles. In parallel, a
fraction of the early endosomes attaches to the surface of
mitochondria and VacA is transferred. VacA eventually accumulates
in the mitochondrial inner membrane, forming chloride channels.
Dissipation of the mitochondrial membrane potential causes
recruitment of Bax and Bak, release of cytochrome c, and apoptosis.
Abbreviations: Bak, Bcl-2-homologous antagonist/killer; Bax, Bcl-2-
associated × protein; CD, “cluster of differentiation” (defined
molecules of the cell surface); Cdc, “cell division cycle” (indicating a
protein involved in the control of the cell cycle); GPI,
glycosylphosphatidylinositol (a glycolipid, often attached to the C-
terminus of a protein to mediate association with membranes); Rab,
“Ras-related in brain” (the Rab family is part of the Ras superfamily
of small GTPases); Ras, “rat sarcoma"; Rho, “ras homologous"; TOM,
translocase of the mitochondrial outer membrane (a protein
complex in the mitochondrial outer membrane mediating protein
translocation); VacA, vacuolating cytotoxin A.
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ability of VacA also determines the possible activities of
VacA in mitochondria.
The traffic route: (IV) Mitochondria
For a long time, intracellular VacA was only detected in
endosomes and in vacuoles. The first attempts to
express VacA in the cytosol of HeLa cells confirmed
this concept. VacA was found to co-localize with the V-
ATPases in the membranes of vacuoles [84]. A few
years later, the group of Patrice Boquet decided to
express different fusion proteins of VacA containing a
green fluorescent protein (GFP) domain in HeLa cells
and to determine their distribution. Surprisingly, the
experiments indicated that VacA or parts of VacA may
be transported to mitochondria [5]. It was found that
the C-terminal part of VacA (named p55 or p58) was
retained in the cytosol. However, the N-terminal part of
VacA (named p34 or p37) localized to mitochondria, at
least if a GFP moiety was attached to the N-terminus.
Moreover, the experiments revealed that constructs of
p34 carrying the GFP moiety at the C-terminus - and
thus exposing a free N-terminus - triggered apoptosis of
the cells. Apoptosis was initiated by release of cyto-
chrome c, it could be inhibited by Bcl-2 [5].
However, in these experiments, the VacA constructs
were only shown to target mitochondria if synthesized
in the cytosol. Unfortunately, it was completely unclear
how VacA may ever encounter mitochondria if provided
by bacteria, or if contained in endosomes. Independent
studies then confirmed that purified VacA was an effi-
cient mediator of apoptosis if added to intact cells from
the outside [6,24], and a series of carefully conducted
studies demonstrated that externally added VacA was
indeed transported to mitochondria, causing dissipation
of the mitochondrial membrane potential, release of
cytochrome c and apoptosis [25,26,85].
Although it was obvious that VacA can trigger apop-
tosis by interactions with mitochondria, the molecular
mechanisms continued to be enigmatic [4,31]. Several
questions were completely unclear: What is the mito-
chondrial targeting signal of VacA? What is the target
structure of VacA inside the mitochondria? What is the
p a t h w a yo fV a c Af r o mt h ep l a s m am e m b r a n et ot h e
mitochondria? What is the mechanism of cytochrome c
release if VacA enters mitochondria? These questions
were recently addressed by several new studies.
What is the mitochondrial targeting signal of VacA?
The biogenesis of endogenous mitochondrial proteins is
very well characterized [86,87]. Several different mito-
chondrial targeting signals have been identified. These
can be located at the N-terminus or at the C-terminus
of a protein, and also internal targeting signals are
known [87]. No such signal sequence is contained in the
primary structure of VacA. By testing different segments
of VacA for mitochondrial targeting in intact cells and
in a cell-free system in vitro, it turned out that the 32
amino acid residues of the VacA N-terminus are neces-
sary and sufficient for targeting to mitochondria [58].
This part of VacA represents a new and peculiar
mitochondrial targeting sequence, there are no obvious
similarities to any endogenous mitochondrial proteins.
The mitochondrial targeting sequence of VacA does
not contain any charged residues, most residues are
hydrophobic. The sequence targets VacA to the TOM
complex of the mitochondrial outer membrane (the
translocase of the mitochondrial outer membrane)
which mediates the import of mitochondrial precursor
proteins from the cytosol. The VacA N-terminus had
previously been known to be essential in the formation
of vacuoles [3,4], and it had been suggested that the
N-terminus may form the ion channel in VacA oligo-
mers [88]. However, the more recent data indicate that
pore-formation by VacA is independent of the N-ter-
minus. It was found that the N-terminal domain of
VacA (p34, residues 1-311) is able to form the charac-
teristic anion channel of low conductivity even if the
N-terminal residues 1-32 are completely deleted [58].
It is therefore conceivable that the hydrophobic VacA
N-terminus primarily serves as a targeting signal and
as a mediator of membrane insertion. In fact, there is
some experimental evidence that the VacA N-terminus
is also in vacuoles primarily required for efficient
membrane insertion and not for oligomerization or
pore formation [89].
What is the target structure of VacA inside the
mitochondria?
The hydrophobic N-terminus of the VacA toxin is not
simply a mediator of unspecific insertion into the mito-
chondrial outer membrane. Two independent studies
found that VacA seems to exclusively accumulate in the
mitochondrial inner membrane [58,90]. The mechanism
that directs VacA specifically to the inner membrane is
still unknown. However, the localization has important
implications. Import of VacA into mitochondria quickly
entails a dissipation of the mitochondrial membrane
potential [5,25]. This effect is probably caused by the
conductivity of the VacA ion channel in the inner mem-
brane. In a first step, chloride ions should diffuse into
the mitochondrial matrix, causing a hyperpolarization of
the membrane potential. In a second step, the function
of the mitochondrial respiratory chain appears to be
compromised, causing an irreversible loss of the mem-
brane potential.
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to the mitochondria?
For 10 years it had been difficult to reconcile the actions
of VacA on mitochondria with the obvious tendency of
externally added VacA to accumulate in endosomes.
The study of Gauthier et al. (ref. [78]) demonstrated a
striking mobility of the endosomes in the cytosol, raising
the question if VacA may be transferred from the endo-
somes to mitochondria upon direct contact. Experimen-
tal evidence supporting this possibility was provided
o n l yr e c e n t l yb yah i g h l ys i g n i f i c a n ts t u d y[ 9 1 ] .T h e
authors investigated the pathway of externally added
VacA from the plasma membrane into the interior of
mouse embryonic fibroblasts and determined the intra-
cellular location of VacA at different time points. In
these experiments, VacA-containing endosomes were
observed in direct contact with mitochondria. The endo-
some-mitochondria juxtaposition was strictly dependent
on VacA, but surprisingly also on a recruitment of Bax
and Bak to the endosomal membranes. After about 12
hours, significant amounts of VacA were detected in the
mitochondrial fraction, clearly preceding the induction
of apoptosis. The transfer to mitochondria was comple-
tely blocked with mutant versions of VacA containing
an amino acid exchange within the N-terminal 32 resi-
dues (P9A or G14A, respectively). Based on previous
assumptions, the authors proposed that the transfer
might be dependent on the VacA channel activity. How-
ever, taking into account the notion of the VacA N-ter-
minus acting as a targeting signal [58], it is more likely
that the N-terminus is involved in direct interactions
with the mitochondrial protein import machinery [7].
Eventually, it is also remarkable that the authors showed
a transfer of the entire holo-toxin to the mitochondria.
In previous studies it had been unclear if the complete
VacA, or possibly only the toxic N-terminal domain
enters the mitochondria.
The mechanism of cytochrome c release: VacA
and apoptosis
Why is apoptosis a consequence of VacA import into
mitochondria? As discussed in this review, there is now
direct evidence of VacA targeting the mitochondrial
inner membrane, and ample evidence of VacA forming
anion channels. An enzymatic activity of VacA seems to
be lacking, and there is no indication that VacA may act
by direct interactions with cellular enzymes or protein
complexes that are directly involved in the regulation of
the cell cycle. Hence, the formation of an anion channel
of low conductivity in the mitochondrial inner mem-
brane is currently the only activity of VacA in mito-
chondria that is supported by the available data. If this
is true, VacA-dependent apoptosis should efficiently be
blocked by reagents that block the VacA channel
activity. Interestingly, experiments of this type have
already been conducted. NPPB (5-nitro-2-[3-phenylpro-
pylamino] benzoic acid) is a chloride channel blocker
that completely inhibits the conductivity of VacA
[58,92,93]. If cells are pre-incubated with this reagent,
they are resistant against VacA-dependent apoptosis
[25]. This correlation is currently the best evidence of
an essential role of the VacA ion channel in VacA-
dependent apoptosis.
Strikingly, H. pylori itself is able to actively suppress
the apoptotic action of its VacA toxin. Cells that receive
the H. pylori CagA protein (by type IV-secretion; see
the contribution of S. Backert in this issue) are resistant
against VacA. CagA initiates a signalling cascade that
stops the uptake of VacA in an early step, probably in
the GPI-anchored proteins-enriched early endosomal
compartments [94]. The effect of CagA confirms the
relevance of an unrestricted access of VacA to mito-
chondria in VacA-induced apoptosis.
Concerning the mechanistic relation of ion channel
formation in the mitochondrial inner membrane to sub-
sequent apoptosis, essentially three points have been
clarified: (i) Import of VacA causes loss of the mito-
chondrial membrane potential [5,25,85], (ii) members of
the Bcl-2 family, including Bax and Bak are intrinsically
involved in VacA-dependent apoptosis
[5,26,29,30,91,95], and (iii) cytochrome c and other
mitochondrial proteins are released into the cytosol
[5,26,29,31,85].
Unfortunately, data are lacking to explain why chlor-
ide influx into the mitochondrial matrix causes Bax and
Bak recruitment at the mitochondrial outer surface. The
functional relation of these two events is currently the
missing link in research on VacA-induced apoptosis. It
is known that any dissipation of the mitochondrial
membrane potential can be sufficient to cause dramatic
structural changes within the mitochondria, including a
significant redistribution of pro-apoptotic factors
[96-98]. However, it seems to be difficult to explain
these consequences in molecular terms. The difficulties
are in part due to the fact that in general only very little
is known about the communication between the mito-
chondrial inner and outer membrane. Further research
on the functions of the VacA toxin is required to eluci-
date this relation.
Conclusions
The epithelial cells of the gastric mucosa undergo apop-
tosis after a few days irrespective of any infection. In the
beginning it was therefore difficult to determine if H.
pylori interferes with this process by specific means or
only as an unspecific mediator of inflammation. It is
now well established that H. pylori can trigger apoptosis
both by the death receptor pathway and by the
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drial pathway received most attention after if had been
found that the VacA toxin of H. pylori can efficiently
trigger apoptosis by direct interactions with mitochon-
dria. The pathway of VacA from the plasma membrane
to the mitochondria of the host cells had been enigmatic
for 10 years. Most data suggested that VacA should
bypass the mitochondria and accumulate exclusively in
late endosomes. Only very recently, in this respect sev-
eral important questions could be answered (Figure 1):
Following uptake at lipid rafts, VacA is contained in
GPI-anchored proteins-enriched early endosomal com-
partments. VacA appears to stay in endosomal mem-
branes, there is no evidence that substantial amounts of
VacA are released into the cytosol. However, early endo-
somes containg VacA can recruit actin at their outer
surface, tails of F-actin can form at one pole of the
endosomes, and together with the endosomes, VacA has
a remarkable motility inside the cell. VacA is transferred
to mitochondria in direct contact between endosomes
and mitochondria. Inside the mitochondria, VacA accu-
mulates in the inner membrane, obviously forming an
anion channel of low conductivity. Subsequent apoptosis
is essentially a consequence of the formation of a chlor-
ide channel in the mitochondrial inner membrane.
Transfer to the mitochondria and insertion into the
mitochondrial inner membrane is mediated by the VacA
N-terminus. Apotosis is initiated by dissipation of the
mitochondrial membrane potential, recruitment of Bax
and Bak, and release of cytochrome c and other pro-
apoptotic proteins into the cytosol.
The next three big questions to be answered are prob-
ably the following: (1.) What exactly is the structure and
the topology of the VacA complexes in the membranes?
(2.) What is the mechanism of the transfer of VacA
from the endosomes to the mitochondria? (3.) What is
the mechanism that links the formation of the ion chan-
nel in the mitochondrial inner membrane to the activa-
tion of Bax and Bak and to the release of pro-apoptotic
factors? Perhaps it will again take 10 years to answer
these questions. However, answers to these questions
would not only clarify a central mechanism of H. pylori-
induced gastro-duodenal diseases, they should also help
to understand the mechanisms of apoptosis in general.
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